Veriluce Therapeutics Revenue

Biotechnology Research • Toronto, Ontario, Canada • 1-10 Employees

Veriluce Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Veriluce Therapeutics

Elena Frigerio

Founder

Company overview

Headquarters	33 Petman Ave., Toronto, Ontario M4S2S9, CA
Phone number	+16479651963
Website	verilucetherapeutics.com
SIC	283
Founded	2017
Employees	1-10
Socials

Veriluce Therapeutics Email Formats

Veriluce Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@verilucetherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@verilucetherapeutics.com	100%

About Veriluce Therapeutics

VeriLuce Therapeutics is an early stage drug development Company focusing in oncology and rare diseases

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Veriluce Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Veriluce Therapeutics has never raised funding before.

Veriluce Therapeutics Tech Stack

Discover the technologies and tools that power Veriluce Therapeutics's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

Hosting

GoDaddy Website Builder

CMS

Open Graph

Miscellaneous

HSTS

Security

RequireJS

JavaScript frameworks

React

JavaScript frameworks

PWA

Miscellaneous

Frequently asked questions

Veriluce Therapeutics is located in Toronto, Ontario, CA.

You can reach Veriluce Therapeutics at +16479651963.

Veriluce Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Veriluce Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Veriluce Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Veriluce Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Veriluce Therapeutics

Elena Frigerio

Founder

4.8

40,000 users